Published in

Springer, Annals of Hematology, 7(100), p. 1919-1919, 2021

DOI: 10.1007/s00277-021-04503-1

Links

Tools

Export citation

Search in Google Scholar

Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma

Journal article published in 2021 by Ryszard Swoboda, Sebastian Giebel, Wanda Knopińska-Posłuszny, Ewa Chmielowska, Joanna Drozd-Sokołowska, Ewa Paszkiewicz-Kozik, Waldemar Kulikowski, Michał Taszner, Włodzimierz Mendrek, Jacek Najda, Tomasz Czerw, Magdalena Olszewska-Szopa ORCID, Anna Czyż, Agnieszka Giza, Wojciech Spychałowicz and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

A Correction to this paper has been published: 10.1007/s00277-021-04503-1